Established in 1962, Rockland Immunochemicals Inc. is a global biotechnology company manufacturing leading edge research tools for basic, applied and clinical research in functional genomics, gene therapy and drug discovery markets. Rockland is a privately held company which operates a manufacturing facility with antibody and protein production capabilities located near Philadelphia, Pennsylvania, USA. European and Asian markets are supported through a highly specialized network of key distributors. Our laboratories consist of over 60,000 square feet, producing antibodies and antibody-based tools that are used to help define mechanisms underlying cell function and disease.

Our reputation is based on attention to detail, customer service and continuous investment in the tools and technologies required to develop a world-class product line. We understand and appreciate how our products are helping solve significant global problems in life science research. We take great care to validate our products before they reach any research laboratory. Every lot of every product is quality-control tested to a rigorous standard and application-tested for consistent performance.

Commercialization: Antibodies produced by Rockland Immunochemicals Inc. are suited for performing high throughput screening (HTS), drug discovery, diagnostic kit production and life science research. Primary antibodies are offered as off the shelf reagents and target Apolipoproteins, Apoptosis / Cell Cycle, Cytokines, Epigenetics, Extracellular Matrix and Transcription Factors. Secondary antibodies are conjugated to a broad range of enzymes and fluorophors. Rockland Immunochemicals Inc. has the ability to custom produce antibodies which can be purified and conjugated to user's exact specifications.